The effect of genistein on lipid levels and LDLR, LXRα and ABCG1 expression in postmenopausal women with hyperlipidemia

Table 3 The effect of genistein on lipid levels of women (mean ± SD)

Lipids		Baseline	6 months	^ap	^bp
Cholesterol (mmol/L)	PG	6.7 ± 1.1	6.6 ± 1.1	0.2108	0.199
Cholesterol (mmol/L)	EG	6.7 ± 1.1	6.1 ± 1.1	0.0283
Triglyceride (mmol/L)	PG	3.0 ± 1.1	3.0 ± 1.2	0.3382	0.001
Triglyceride (mmol/L)	EG	3.0 ± 0.9	2.4 ± 1.1	0.0006
HDL-C (mmol/L)	PG	1.1 ± 0.2	1.0 ± 0.3	0.2391	0.438
HDL-C (mmol/L)	EG	1.1 ± 0.1	1.2 ± 0.1	0.0131
LDL-C (mmol/L)	PG	5.3 ± 1.1	5.3 ± 1.4	0.3912	0.000
LDL-C (mmol/L)	EG	5.2 ± 1.0	3.8 ± 0.6	0.0015
HDL/LDL (mmol/L)	PG	0.2 ± 0.1	0.2 ± 0.1	0.3732	0.003
HDL/LDL (mmol/L)	EG	0.2 ± 0.1	0.3 ± 0.1	0.0013
Apo-A1 (g/L)	PG	1.19 ± 0.04	1.18 ± 0.02	0.2117	0.438
Apo-A1 (g/L)	EG	1.19 ± 0.03	1.19 ± 0.02	0.4201
Apo-B (g/L)	PG	1.01 ± 0.04	1.00 ± 0.03	0.2301	0.044
Apo-B (g/L)	EG	1.02 ± 0.04	0.68 ± 0.06	0.0469

PG Placebo group, EG experiment group
Experimental conditions and treatment procedures are given in Materials and methods. Graph depicts (mean ± SD). ^ap value denotes the comparison of mean changes from respective baseline between the experiment group and placebo group by two-sample t test. ^bp value indicates the comparison of mean change from respective baseline between the experiment and placebo group were evaluated by Tukey test. PG Placebo group, EG experiment group

ISSN: 1758-5996